BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11739519)

  • 1. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection.
    Serbina NV; Lazarevic V; Flynn JL
    J Immunol; 2001 Dec; 167(12):6991-7000. PubMed ID: 11739519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.
    Ordway D; Higgins DM; Sanchez-Campillo J; Spencer JS; Henao-Tamayo M; Harton M; Orme IM; Gonzalez Juarrero M
    J Leukoc Biol; 2007 Nov; 82(5):1221-9. PubMed ID: 17699612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis.
    Caruso AM; Serbina N; Klein E; Triebold K; Bloom BR; Flynn JL
    J Immunol; 1999 May; 162(9):5407-16. PubMed ID: 10228018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice.
    Lazarevic V; Yankura DJ; DiVito SJ; Flynn JL
    Infect Immun; 2005 May; 73(5):2910-22. PubMed ID: 15845497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.
    Palma C; Schiavoni G; Abalsamo L; Mattei F; Piccaro G; Sanchez M; Fernandez C; Singh M; Gabriele L
    Eur J Immunol; 2013 Sep; 43(9):2386-97. PubMed ID: 23719937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses.
    Lazarevic V; Nolt D; Flynn JL
    J Immunol; 2005 Jul; 175(2):1107-17. PubMed ID: 16002712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice.
    Serbina NV; Flynn JL
    Infect Immun; 1999 Aug; 67(8):3980-8. PubMed ID: 10417164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection.
    Bold TD; Ernst JD
    J Immunol; 2012 Sep; 189(5):2530-6. PubMed ID: 22837486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis.
    Serbina NV; Flynn JL
    Infect Immun; 2001 Jul; 69(7):4320-8. PubMed ID: 11401969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype.
    Lyadova IV; Oberdorf S; Kapina MA; Apt AS; Swain SL; Sayles PC
    Clin Exp Immunol; 2004 Oct; 138(1):21-9. PubMed ID: 15373901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
    Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
    J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of antigen-specific T cells with limited functional capacity during Mycobacterium tuberculosis infection.
    Jeong YH; Jeon BY; Gu SH; Cho SN; Shin SJ; Chang J; Ha SJ
    Infect Immun; 2014 Jan; 82(1):132-9. PubMed ID: 24126533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection.
    Lu YJ; Barreira-Silva P; Boyce S; Powers J; Cavallo K; Behar SM
    Cell Rep; 2021 Sep; 36(11):109696. PubMed ID: 34525366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages.
    Serbina NV; Liu CC; Scanga CA; Flynn JL
    J Immunol; 2000 Jul; 165(1):353-63. PubMed ID: 10861072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production.
    Tsukaguchi K; Balaji KN; Boom WH
    J Immunol; 1995 Feb; 154(4):1786-96. PubMed ID: 7836763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels.
    Mutis T; Cornelisse YE; Ottenhoff TH
    Eur J Immunol; 1993 Sep; 23(9):2189-95. PubMed ID: 8103743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
    Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
    J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.